Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Cervical Cancer
100%
Therapeutic Vaccine
100%
E7 Oncoprotein
100%
E6 Oncoprotein
100%
Deoxyribonucleic Acid
100%
Detox
40%
Cancer Treatment
20%
Clinical Trials
20%
Effective Treatment
20%
Clinical Efficacy
20%
Treatment Regimen
20%
High Purity
20%
Public Health Risk
20%
Nucleic Acids
20%
Human Papillomavirus Vaccine
20%
Treatment Strategy
20%
Virus
20%
Causative Agents
20%
Protein-based
20%
Common Cancers
20%
Preventive Treatment
20%
Immunogenicity
20%
Viral Clearance
20%
Cervical Lesions
20%
Heat Shock Protein 70 (HSP70)
20%
Phase I Trial
20%
Conservative Treatment
20%
Phase II Trial
20%
Screening Approach
20%
Long-term Survival
20%
High Mortality Rate
20%
T Cell Immune Response
20%
Preventive Screening
20%
Live Vector
20%
Viral Eradication
20%
Vaccine Types
20%
Vaccine Response
20%
Preventative Approach
20%
Clinical Implementation
20%
Pharmacology, Toxicology and Pharmaceutical Science
DNA
100%
Uterine Cervix Cancer
100%
Human Papillomavirus
100%
Protein E7
100%
Protein E6
100%
Therapeutic Vaccine
100%
Malignant Neoplasm
40%
Viral Clearance
40%
Phosphoryl Lipid A
40%
Nucleic Acid
20%
Side Effect
20%
Clinical Trial
20%
Mortality Rate
20%
Phase I Trials
20%
Immunogenicity
20%
Wart Virus Vaccine
20%
Long Term Survival
20%
Phase II Trials
20%
Disease
20%
INIS
cancer
100%
humans
100%
reviews
100%
vaccines
100%
deoxyribonucleic acid
100%
cost
11%
mortality
11%
women
11%
people
11%
implementation
11%
proteins
11%
vectors
11%
clinical trials
11%
screening
11%
public health
11%
purity
11%
viruses
11%
nucleic acids
11%
side effects
11%
clearance
11%
Immunology and Microbiology
Vaccine Efficacy
100%
Wart Virus
100%
Viral Clearance
25%
Phosphoryl Lipid A
25%
Adoptive Immunity
12%
Immunogenicity
12%
Cervarix
12%
Mortality Rate
12%
Long Term Survival
12%
T Cell
12%